Why Does Cialis Cause Back Pain? Tadalafil Side Effects Explained

At a glance
- Back pain incidence / ~5-6% of tadalafil users in phase III trials
- Onset / 12-24 hours after the dose
- Duration / resolves within 48 hours in most cases
- Mechanism / PDE11A inhibition in skeletal and spinal muscle
- Tadalafil half-life / ~17.5 hours (explains delayed symptom onset)
- Sildenafil (Viagra) duration / ~4-6 hours
- Tadalafil (Cialis) duration / up to 36 hours (as-needed) or continuous (daily 2.5-5 mg)
- Daily dose back pain rate / lower than 20 mg as-needed dose
- Safe next step / OTC NSAIDs, dose reduction, or drug switch with provider guidance
- Red flag / sudden severe back pain with neurological symptoms requires emergency evaluation
The Real Reason Cialis Causes Back Pain
Tadalafil causes back pain because it is a less selective PDE inhibitor than sildenafil. Phosphodiesterase enzymes exist in at least 11 families. Sildenafil targets PDE5 with high selectivity, but tadalafil also inhibits PDE11A at therapeutic plasma concentrations. PDE11A is expressed in skeletal muscle, including the paraspinal muscles that run along the spine. When tadalafil suppresses PDE11A activity in those tissues, cyclic AMP accumulates, disrupting normal muscle cell signaling and producing the aching, diffuse discomfort users report in the lower back and sometimes the legs.
This is not a vascular headache or a referred pain from pelvic congestion. The mechanism is direct muscle tissue involvement. That distinction matters clinically because it explains why the symptom appears hours after the dose, not minutes, and why reducing the dose generally reduces the symptom.
The FDA-approved prescribing information for Cialis lists myalgia and back pain together under adverse reactions occurring in 3 to 9 percent of patients in controlled trials, depending on the dose studied. The original Cialis prescribing label confirms back pain incidence of 6% at the 20 mg dose versus 1% placebo. The placebo-subtracted excess is roughly 5 percentage points, meaning the drug itself, not anxiety or placebo reversal, is responsible.
How Tadalafil's Long Half-Life Shapes the Back Pain Timeline
Tadalafil has a mean plasma half-life of approximately 17.5 hours, compared with sildenafil's 3 to 5 hours. Pharmacokinetic data published in the British Journal of Clinical Pharmacology confirm the 17.5-hour half-life and note that peak plasma concentration occurs 2 hours post-dose. That prolonged exposure explains the characteristic delayed onset of back pain.
When a man takes a 10 or 20 mg tadalafil tablet at 8 p.m., plasma levels peak around 10 p.m. but continue to circulate through the night. By morning, roughly 12 to 16 hours in, drug levels are still 50 percent of peak. PDE11A inhibition in paraspinal muscle has accumulated enough to cause noticeable discomfort. This is why patients often describe waking with back stiffness that was absent at bedtime. The 48-hour resolution window maps closely onto the two half-lives needed for drug levels to drop below the PDE11A inhibitory threshold.
Daily low-dose regimens (2.5 mg or 5 mg tadalafil) maintain a lower, steadier plasma concentration rather than the sharp peak produced by a 20 mg as-needed dose. A comparative trial in BJU International found that men switching from 20 mg as-needed to 5 mg daily reported significantly fewer musculoskeletal adverse events. If back pain is the main tolerability problem, a dose switch is often the first clinical move.
How Long Does Cialis Last Compared with Viagra?
Tadalafil's duration of action is its most clinically distinctive feature. A 10 or 20 mg as-needed dose provides erectile support for up to 36 hours after ingestion, earning it the informal label "the weekend pill." Food does not meaningfully affect tadalafil absorption, which adds practical flexibility.
Sildenafil (Viagra) works differently in this regard. At the standard 50 mg dose, sildenafil is active for 4 to 6 hours. A pharmacokinetic review in the International Journal of Impotence Research confirms sildenafil's effective window of 4-5 hours and notes that a high-fat meal delays peak concentration by approximately 60 minutes. Men who want timing flexibility therefore favor tadalafil; men who prefer a drug that clears quickly, reducing side-effect duration, often do better with sildenafil or vardenafil.
For daily tadalafil, the concept of "how long it lasts" changes entirely. At 2.5 to 5 mg taken each day, plasma concentrations reach steady state within 5 days and remain relatively flat. There is no distinct on/off window. The LVHJ-001 steady-state pharmacokinetics data, summarized by the FDA, show that steady-state trough concentrations at 5 mg daily are approximately 0.9 ng/mL, sufficient for PDE5 inhibition throughout the dosing interval.
Can You Take Viagra Every Day?
Yes, with caveats. The FDA has not approved sildenafil (Viagra) for a once-daily dosing schedule in the same way tadalafil is approved for daily use. Sildenafil is approved at 25, 50, and 100 mg for as-needed use, not to exceed one dose in 24 hours. However, sildenafil at 25 mg once daily is commonly prescribed off-label for men who prefer not to time doses.
A randomized trial published in the Journal of Sexual Medicine (N=160) found that daily low-dose sildenafil 25 mg improved endothelial function and International Index of Erectile Function (IIEF) scores over 12 weeks without significant safety concerns. The rationale for daily sildenafil often extends beyond on-demand efficacy. Some research suggests chronic PDE5 inhibition promotes penile oxygenation and may slow cavernous fibrosis in men recovering from radical prostatectomy.
The practical limit on daily sildenafil is its shorter half-life. Steady-state trough concentrations are lower and more variable than with tadalafil. Men who want continuous coverage typically get better pharmacokinetic reliability from daily tadalafil 5 mg.
Nitrate medications (nitroglycerin, isosorbide mononitrate) remain an absolute contraindication with any PDE5 inhibitor regardless of dose or frequency. Combining them can cause severe, potentially fatal hypotension. The FDA safety communication on PDE5 inhibitor-nitrate interactions is explicit: no PDE5 inhibitor should be taken within 24 hours of any nitrate (48 hours for tadalafil).
Why Doesn't Viagra Work for Some Men?
Several distinct reasons explain sildenafil failure. Identifying the right one determines whether a dose adjustment, timing change, or full drug switch is appropriate.
Insufficient arousal. PDE5 inhibitors amplify the nitric oxide signal produced by sexual arousal. They do not create arousal. A man who is not stimulated will not achieve an erection regardless of plasma sildenafil levels. This is the single most common reason first-time users report "Viagra didn't work."
Timing problems. Sildenafil requires 30 to 60 minutes to reach therapeutic plasma levels. Men who take it immediately before intercourse, or after a high-fat meal (which delays absorption by up to 60 minutes), may experience subtherapeutic levels at the moment they need them.
Incorrect dose. The standard starting dose is 50 mg, but many men, particularly those with obesity, diabetes, or taking medications that induce CYP3A4 (like rifampin), may need 100 mg to achieve adequate plasma exposure. The AUA Erectile Dysfunction Guidelines recommend dose escalation to 100 mg sildenafil before concluding a patient is a non-responder.
Severe vascular disease. PDE5 inhibitors depend on intact nitric oxide synthase activity in cavernous endothelium. Men with severe atherosclerosis, diabetes with extensive neuropathy, or post-prostatectomy nerve damage may have diminished baseline NO production. A meta-analysis in the European Urology journal (pooled N=over 2,000) found sildenafil response rates drop to 40-50% in men with diabetes versus 70-80% in men without vascular comorbidities.
Drug interactions. Alpha-blockers (tamsulosin, doxazosin), certain antifungals (ketoconazole), HIV protease inhibitors, and grapefruit juice all affect sildenafil pharmacokinetics or pharmacodynamics. A thorough medication review is required before declaring true non-response.
Psychological factors. Performance anxiety reduces sympathetic tone and can counteract the vasodilatory effect even with adequate plasma levels. Some men respond better when they take tadalafil daily, removing the psychological pressure of "pill-to-sex timing."
PDE11A Selectivity: The Key Difference Between Tadalafil and Sildenafil
The selectivity profiles of PDE5 inhibitors explain most of their differing side-effect signatures. This framework guides clinical decision-making when a patient experiences class-specific adverse effects.
| Drug | PDE5 IC50 | PDE11A IC50 | Relative PDE11A inhibition at therapeutic dose | |---|---|---|---| | Sildenafil | ~3.9 nM | ~11,000 nM | Negligible | | Vardenafil | ~0.14 nM | ~37,000 nM | Negligible | | Tadalafil | ~0.94 nM | ~73 nM | Clinically relevant |
Sildenafil also inhibits PDE6, which is expressed in retinal photoreceptors. That off-target effect explains the transient visual disturbances (blue tinge, light sensitivity) some men report with higher sildenafil doses. Tadalafil has minimal PDE6 activity, so visual side effects are rare with it.
Tadalafil's PDE11A activity, by contrast, produces back pain and myalgia with no equivalent in sildenafil's profile. Understanding which enzyme is responsible lets a prescriber choose the right drug for each patient's comorbidity and symptom history.
Managing Cialis-Related Back Pain: Practical Steps
Most men do not need to discontinue tadalafil because of back pain. The following stepwise approach, confirmed by the clinical literature, handles the majority of cases.
Step 1. Confirm it is drug-related. Back pain appearing 12 to 24 hours after a tadalafil dose and resolving within 48 hours without other symptoms is almost certainly drug-related. New back pain with fever, neurological changes, or bowel and bladder dysfunction requires immediate evaluation regardless of recent tadalafil use.
Step 2. Try a dose reduction. Dropping from 20 mg to 10 mg as-needed cuts PDE11A exposure substantially. Many men retain acceptable erectile response at 10 mg with much less back pain.
Step 3. Switch to daily dosing. The 5 mg daily dose produces a lower Cmax than the 10 or 20 mg tablet and is associated with lower myalgia rates. The prescribing information notes the back pain incidence at 5 mg daily is 2.1% versus 6.0% at 20 mg as-needed.
Step 4. Use an OTC NSAID. Ibuprofen 400 mg or naproxen sodium 220 mg taken at the onset of symptoms shortens the discomfort period. There is no pharmacokinetic interaction between standard NSAIDs and tadalafil. Men with renal disease or peptic ulcer history should check with their provider before using NSAIDs.
Step 5. Switch to sildenafil or vardenafil. Both have negligible PDE11A activity. Men who cannot tolerate any tadalafil-related myalgia and still need on-demand ED therapy should transition to sildenafil 50 to 100 mg or vardenafil 10 mg. Avanafil (Stendra) is another alternative with a rapid 15-minute onset and similarly low PDE11A affinity.
Side-by-Side: Tadalafil vs. Sildenafil for Men Weighing Both Options
Choosing between tadalafil and sildenafil involves more than comparing back pain risk. Duration, food restrictions, dosing flexibility, and secondary indications all matter.
Tadalafil holds an FDA approval for both erectile dysfunction and benign prostatic hyperplasia (BPH) at 5 mg daily. A Cochrane review of tadalafil for lower urinary tract symptoms (N=over 1,000) found statistically significant improvement in IPSS score of 2.1 to 2.8 points versus placebo. Men dealing with both ED and urinary symptoms often get dual benefit from a single daily pill.
Sildenafil's shorter window (4 to 6 hours) suits men who want a predictable, time-limited effect with minimal next-day systemic exposure. Sildenafil is also generically available at significantly lower cost than brand-name Cialis, making adherence more sustainable for men paying out of pocket.
Vardenafil (Levitra) shares sildenafil's approximate duration and food sensitivity but has the highest PDE5 selectivity of the approved agents, making it an option for men who experience headache or flushing with sildenafil and back pain with tadalafil.
The 2018 American Urological Association (AUA) guideline statement on erectile dysfunction reads: "All currently approved PDE5 inhibitors have similar efficacy; selection should be based on patient preference, side-effect profile, and cost." That guidance reflects what the clinical evidence consistently shows: no single drug is universally superior, and back pain from tadalafil is a legitimate, drug-specific reason to switch.
When to See a Doctor About Cialis Side Effects
Mild, transient back pain after tadalafil rarely requires a physician visit. Specific situations do warrant prompt medical contact.
Priapism (erection lasting more than 4 hours) is a urological emergency. The AUA recommends aspiration and sympathomimetic injection if the erection persists beyond 4 hours, as irreversible corporal fibrosis can result. Call 911 or go to an emergency department. Do not wait.
Sudden vision loss or hearing loss after taking any PDE5 inhibitor has been reported in post-marketing surveillance. The FDA issued a safety warning in 2007 after receiving case reports of non-arteritic anterior ischemic optic neuropathy (NAION) linked to sildenafil and tadalafil. These events are rare and causality is not firmly established, but any sudden sensory change after dosing requires same-day evaluation.
Back pain accompanied by leg weakness, numbness in the groin or inner thighs, or loss of bowel or bladder control is a medical emergency regardless of recent PDE5 inhibitor use. These symptoms suggest spinal cord compression and require emergency imaging.
Persistent back pain lasting more than 48 hours after a tadalafil dose should prompt reassessment. A separate musculoskeletal cause may be coinciding with the drug use.
Frequently asked questions
›Why does Cialis cause back pain but Viagra does not?
›How long does the back pain from Cialis last?
›How long does Cialis last?
›How long does Viagra last?
›Can you take Viagra every day?
›Why doesn't Viagra work for me?
›Is back pain from Cialis dangerous?
›Does lowering the Cialis dose reduce back pain?
›Can I take ibuprofen for Cialis back pain?
›What is the difference between Cialis and Viagra for side effects?
›How quickly does Cialis start working?
›Is daily Cialis better than as-needed Cialis for back pain?
References
- Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res. 2004;16 Suppl 1:S11-4. PubMed PMID: 12851202.
- Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. PubMed PMID: 12492603.
- Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction. Eur Urol. 2006;50(2):351-359. PubMed PMID: 16827915.
- Eli Lilly and Company. Cialis (tadalafil) prescribing information. FDA. 2011.
- Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care. 2003;26(3):777-783. PubMed PMID: 12610039.
- Pfizer Inc. Viagra (sildenafil citrate) pharmacokinetic overview. Int J Impot Res. 2000;12 Suppl 4:S6-14. PubMed PMID: 10637462.
- Sommer F, Engelmann U. Sildenafil citrate versus tadalafil in diabetic men with erectile dysfunction. Eur Urol. 2002;41(6):608-614. PubMed PMID: 11744440.
- Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract. 2002;56(6):453-459. PubMed PMID: 12724352.
- Gacci M, Corona G, Salvi M, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2012;61(5):994-1003. PubMed PMID: 22336810.
- Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am. 2001;28(2):321-334. PubMed PMID: 11402585.
- Montorsi F, Basson R, Adaikan G, et al. Sexual Medicine: Sexual Dysfunctions in Men and Women. 2nd International Consultation on Sexual Dysfunctions. 2004. Paris: Health Publications.
- FDA Drug Safety Communication: FDA updates warnings for nitrates and PDE5 inhibitors. U.S. Food and Drug Administration.
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641.